Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis

Kidney International

Volumn 63, Issue 6, 2003, Pages 2214-2221

  Iodice, Carmela ^b   Balletta, Mario M ^b   Minutolo, Roberto ^b   Giannattasio, Paolo ^b   Tuccillo, Stefano ^b   Bellizzi, Vincenzo ^b   D'Amora, Maurizio ^b   Rinaldi, Giorgio ^b   Signoriello, Giuseppe ^b   Conte, Giuseppe ^b   De Nicola, Luca ^a  

^a NONE   (Italy)

^b NONE

Author keywords

Angiotensin receptor antagonist; Converting enzyme inhibitor; Focal segmental glomerulosclerosis; Membranous nephropathy; SDS PAGE; Urinary 1m

Indexed keywords

ALPHA 1 MICROGLOBULIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; RAMIPRIL;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CREATININE CLEARANCE; DOSE RESPONSE; FEMALE; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HEMOGLOBIN DETERMINATION; HORMONE INHIBITION; HUMAN; KIDNEY FUNCTION; KIDNEY TUBULE DAMAGE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINARY EXCRETION;

EID: 0037513318     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00015.x     Document Type: Article

References (32)

1. RUGGENENTI P, PERNA A, MOSCONI L, et al: Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int 53:1209-1216, 1998
2. REMUZZI G, BERTANI T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38:384-394, 1990
3. D'AMICO G: Tubulointerstitium as predictor of progression of glomerular disease. Nephron 83:289-295, 1999
4. PONTICELLI C, VILLA M, BANFI G, et al: Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis 34:618-625, 1999
5. LALUCK BJ, CATTRAN DC: Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy. Am J Kidney Dis 33:1026-1032, 1999
6. CATTRAN DC, RAO P: Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32:72-79, 1998
7. YAMAGATA K, YAMAGATA Y, KOBAYASHI M, KOYAMA A: A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults. Clin Nephrol 45:281-288, 1996
8. GRIMM RH, SVENDSEN K, KASISKE B, et al: Proteinuria is a risk factor for mortality over 10 years of follow-up. Kidney Int 52(Suppl 63):10-14, 1997
9. DE JONG PE, NAVIS G, DE ZEEUW D: Renoprotective therapy: Titration against urinary protein excretion. Lancet 354:352-353, 1999
10. RUGGENENTI P, SCHIEPPATI A, REMUZZI G: Progression, remission, regression of chronic renal diseases. Lancet 357:1601-1608, 2001
11. RUGGENENTI P, PERNA A, REMUZZI G, et al: ACE inhibitors to prevent end-stage renal disease: When to start and why possibly never to stop: A post hoc analysis of the REIN trial results. J Am Soc Nephrol 12:2832-2837, 2001
12. RUSSO D, PISANI A, BALLETTA MM, et al: Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis 33:851-856, 1999
13. RUSSO D, MINUTOLO R, PISANI A, et al: Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis 38:18-25, 2001
14. HILGHERS KF, MANN JFE: ACE inhibitors versus AT1 receptor antagonists in patients with chronic renal disease. J Am Soc Nephrol 13:1100-1108, 2002
15. BAZZI C, PETRINI C, RIZZA V, et al: Characterization of proteinuria in primary glomerulonephritides. SDS-PAGE patterns: Clinical significance and prognostic value of low molecular weight ("tubular") proteins. Am J Kidney Dis 29:27-35, 1997
16. BAZZI C, PETRINI C, RIZZA V, et al: A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int 58:1732-1741, 2000
17. 1-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. Am J Kidney Dis 38:240-248, 2001
18. DE NICOLA L, BELLIZZI V, MINUTOLO R, et al: Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure. Kidney Int 56:674-684, 1999
19. HEEG JE, DE JONG PE, VAN DER HEM GK, DE ZEEUW D: Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 36:272-279, 1989
20. THOMAS DM, HILLIS AN, COLES GA, et al: Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics. Am J Kidney Dis 18:38-43, 1991
21. GANSEVOORT RT, DE ZEEUW D, DE JONG PE: Is the antiproteinuric effect of ACE inhibition mediated by interference in the reninangiotensin system? Kidney Int 45:861-867, 1994
22. PISONI R, RUGGENENTI P, SANGALLI F, et al: Effect of high dose ramipril with or without indomethacin on glomerular selectivity. Kidney Int 62:1010-1019, 2002
23. LAVERMAN GD, NAVIS G, HENNING RH, et al: Dual renin-angiotensin system blockade at optimal doses for proteinuria. Kidney Int 62:1020-1025, 2002
24. FERRARI P, MARTI HP, PFISTER M, FREY FJ: Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade. J Hypertens 20:125-130, 2002
25. LEWIS EJ, HUNSICKER LG, CLARKE WR, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
26. AGARWAL R: Add-on angiotensin receptor blockade with maximized ACE inhibition. Kidney Int 59:2282-2289, 2001
27. WANG AY, YU AW, LAM CW, et al: Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin growth factor-1 in patients with and without posttransplant erythrocytosis. Am J Kidney Int 39:600-608, 2002
28. MACDOUGALL IC: ACE inhibitors and erythropoietin responsiveness. Am J Kidney Dis 38:649-651, 2001
29. LEVlN A, THOMPSON CR, ETHIER J, et al: Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 34:125-134, 1999
30. NAKAMURA T, OBATA J, KIMURA H, et al: Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 55:877-889, 1999
31. BLANTZ RE, GABBAI FB, TUCKER BJ, et al: Role of mesangial cell in glomerular response to volume and angiotensin II. Am J Physiol 264:F158-165, 1993
32. RUGGENENTI P, MOSCONI L, VENDRAMIN G, et al: ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome. Am J Kidney Dis 35:381-391, 2000